Back to the main directory
Reporting Results / Equity
- FCFS: FirstCash, Inc. - 3Q21 Results: Strong recovery and continued margin strength, but slightly below market expectations by Credit Suisse
- ROG.S: Roche - 3Q21 Second Opinion, COVID solutions continue to more than offset biosimilar erosion by Credit Suisse
- ALPEKA.MX: Alpek S.A. de C.V - 3Q21: Upped guidance implies still-solid 4Q; focus on contract PET margins ahead by Credit Suisse
- VESTA.MX: Vesta, S.AB. De C.V - 3Q21 results: Strong leasing activity drives top-line beat by Credit Suisse
- YAR.OL: Yara International ASA - Product pricing supportive but gas to overhang in FY22 by Credit Suisse
- GFNORTEO.MX: Grupo Financiero Banorte - 3Q21 Results: Stellar asset quality and stronger banking NIM offset continued pressure in insurance by Credit Suisse
- GMXT.MX: GMexico Transportes - Strong 3Q21 as Expected | Weak Pricing Power by Credit Suisse
- HYPE3.SA: Hypera Pharma - 3Q21: The growth continues, but profitability was hit by Credit Suisse
- NEOE3.SA: Neoenergia - 3Q21: Strong Performance from DisCos and Favorable Winds by Credit Suisse
- TIMS3.SA: TIM Participacoes - Q3: Results indicate a gradual revenue acceleration by Credit Suisse
- 4479.T: Makuake - FY9/21 results: Negative near term, but position intact at the frontier of the "process economy" by Credit Suisse
- 6967.T: Shinko Electric Industries - Earnings beat again in 2Q, continued strong performance in 2H expected. No sign of correction in FC packages, to remain firm in 2H by Credit Suisse
- 6923.T: Stanley Electric - 2Q results: Announces buybacks; full-year guidance still TBC, awaiting clarity by Credit Suisse
- 6988.T: Nitto Denko - 2Q FY3/22 results: Profit recovery continues; raises full-year guidance by Credit Suisse
- MRFG3.SA: Marfrig Global Foods - 3Q21: There is still juice in the orange by Credit Suisse
- GFINBURO.MX: G.F. Inbursa - 3Q21 Results: Solid asset quality performance, but retail volumes contract further by Credit Suisse
- VISTAA.MX: Vista Oil Gas - 3Q21 Results: Another one for the goods - Raising TP by Credit Suisse
- CPRI.MI: Davide Campari - Revenge conviviality underpins topline momentum, gross margin recovery pushed out by Credit Suisse
- 4506.T: Sumitomo Dainippon Pharma - Bounced back in 2Q with one-time payment from Otsuka Pharmaceutical tie up, but forecasts profit decline in 2H by Credit Suisse
- 7278.T: Exedy - 2Q FY3/22 results: Curbs raw material costs; performance solid amid ongoing production adjustments, partly on delayed cost booking by Credit Suisse
- 5334.T: NGK Spark Plug - Hikes guidance; sales of aftermarket plugs, SPE components still brisk; forecasts recovery in auto parts from 4Q by Credit Suisse
- 4751.T: CyberAgent - FY9/21 results: Internet advertisement business remains strong by Credit Suisse
- CPX.TO: Capital Power Corporation - At-a-Glance: Moving Past a Miss and Seeing the Structural Successful Set-up by Credit Suisse
- 6501.T: Hitachi - 2Q results: Lowers full-year guidance; Astemo struggling amid chip shortages by Credit Suisse
- ODPV3.SA: OdontoPrev - A new growth cycle? by Credit Suisse